Diseases, Conditions, Syndromes

Bacterial agent opens new therapeutic options for Wilson's disease

A specific molecule excreted by methane-oxidizing bacteria could be most suitable for therapy against Wilson's disease (WD). This is what researchers led by Helmholtz Munich scientist Hans Zischka have found in a new study. ...


AI-based analysis on drug-drug interactions involving Paxlovid

Professor Sang Yup Lee's research team in KAIST's Department of Biochemical Engineering has developed an advanced AI-based drug interaction prediction technology that analyzed the interaction between Paxlovid ingredients ...


Genetic analysis can reduce adverse drug reactions by 30%

Patients can experience 30% fewer serious adverse reactions if their drugs are tailored to their genes, reports a study published in The Lancet. A European collaboration involving researchers from Karolinska Institutet suggests ...

page 1 from 16